NASDAQ:OLMA | Cash Flow Statement | Olema Pharmaceuticals, Inc.

Complete source-backed cash-flow history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$63.2M
2026-03-31-$53.09M$119,000.00-$45.99M$4.53M$45.7M
2025-12-31-$46.06M$187,000.00-$38.33M-$162.18M$213.55M
2025-09-30-$42.22M
2025-06-30-$43.78M
2025-03-31-$30.39M$128,000.00-$43.98M-$45.08M$222,000.00
2024-12-31-$33.57M$116,000.00-$26.28M$0.00-$114.42M$244.3M
2024-09-30-$34.56M
2024-06-30-$30.38M
2024-03-31-$30.97M$88,000.00-$23.5M$153,000.00-$20.14M$8.82M
2023-12-31-$26.77M$88,000.00-$18.48M-$30.92M$523,000.00
2023-09-30-$21.5M
2023-06-30-$20.1M
2023-03-31-$28.29M$100,000.00-$20.39M$37.39M$220,000.00
2022-12-31-$26.18M$97,000.00-$19.71M$173,000.00$16.34M$273,000.00
2022-09-30-$22.72M
2022-06-30-$32.86M
2022-03-31-$23.03M$84,000.00-$17.9M$30,000.00$25.57M$33,000.00
2021-12-31-$21.64M$73,000.00-$18.6M$699,000.00$6M$818,000.00
2021-09-30-$17.71M
2021-06-30-$16.41M
2021-03-31-$15.34M$9,000.00-$11.08M$420,000.00-$279.58M
2020-12-31-$10.13M$4,000.00-$9.01M$51,000.00-$51,000.00$219.79M
2020-09-30-$7.84M
2020-06-30-$2.45M
2020-03-31-$1.69M$3,000.00-$2.14M$9,000.00-$9,000.00$29.99M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$162.45M$490,000.00-$146.72M-$155.76M$211.3M
2024-12-31-$129.47M$393,000.00-$104.35M$159,000.00-$93.53M$268.82M
2023-12-31-$96.66M$377,000.00-$83.73M-$4.85M$133.42M
2022-12-31-$104.79M$357,000.00-$82.07M$363,000.00$91.48M$476,000.00
2021-12-31-$71.1M$163,000.00-$50.69M$1.58M-$275.44M$1.39M
2020-12-31-$22.12M$11,000.00-$19.87M$56,000.00-$56,000.00$358.4M
2019-12-31-$4.32M$9,000.00-$3.08M